Background: Sleep disturbance is a frequent comorbidity in children with autism spectrum disorder (ASD), affecting an estimated 40-80% of cases. Previous reports have shown relationships between several circadian rhythm-related genes and sleep problems in ASD. The purpose of the present study was to relate variation in and around melatonin synthesis and suprachiasmatic nucleus genes to sleep problems in a large sample of children with ASD. Method: This secondary analysis used existing genotypic and phenotypic data for 2,065 children, aged 4-18 years, from the Simons Simplex Collection (SSC). Sleep problems were measured with the SSC Sleep Interview. Expression quantitative trait loci and single nucleotide polymorphisms in 25 circadian genes were chosen primarily for their impact on expression levels of target genes in the brain. Associations between variants and composite sleep problems, nighttime problems, daytime problems, and sleep duration problems were calculated using logistic regression analysis. Age, sex, nonverbal IQ, ASD severity, gastrointestinal distress, seizures, and ancestry were included as covariates. Transmission disequilibrium tests were performed to test for overtransmission of alleles in the same variants. Results: No significant associations or transmission disequilibrium were found between gene variants and sleep problems in this sample of children with ASD. Conclusion: Variation in expression of investigated genes in the melatonin synthesis and suprachiasmatic nucleus pathways did not have notable impacts on sleep problems in this large sample of children with ASD. Future research could explore translational and posttranslational effects of these genes or the effects of genes in other sleep-homeostasis pathways on sleep patterns.
melatonin synthesis pathway. They found two promoter polymorphisms significantly more frequently in individuals with ASD (rs4446909 and rs5989681, p < .000), leading to substantial decreases in ASMT activity (p ¼ 2 Â 10
À12
) and melatonin level (p ¼ 3 Â 10 À11 ). In addition, a splice-site mutation (IVS5 þ 2 T > C) was correlated in ASD with decreased sleep efficiency (70-82% vs. >85% in controls) and increased night wakings (17-22 times/hr vs. <10 times/hr in controls). More recently, Veatch et al. (2015) confirmed a high frequency of the same two ASMT polymorphisms Melke et al. reported (rs4446909 and rs5989681) in a group of 15 unrelated children with ASD and sleep-onset delay.
Although a number of studies have investigated links between suprachiasmatic nucleus (SCN) genes and risk for ASD (Chaste et al., 2011; Goto, Mizuno, Matsumoto, Yang, & Jimbo, 2017; Hu, Sarachana, Sherrard, & Kocher, 2015; Nicholas et al., 2007) , only one study to date has examined multiple SCN genes in relation to sleep patterns in individuals with ASD. Yang et al. (2016) examined 18 genes in individuals with ASD with and without abnormal sleep patterns and in controls. They observed six missense changes exclusively in individuals with ASD and abnormal sleep problems in CLOCK (c.2551A > G), MTNR1B (c.974G > A), PER3 (c.1447C > T, c.1361G > A), NIR1D1 (c.58A > C), and TIMELESS (c.1493T > C). However, they also identified mutations in ARNTL, MTNR1A, MTNR1B, PER1, PER2, PER3, and TIMELESS in individuals with ASD without sleep problems and in PER2 in healthy controls.
To our knowledge, no study has examined the genes of the melatonin synthesis pathway and core SCN pathway together with characteristics of a large sample of children with ASD. Using data from the Simons Simplex Collection (SSC), a large, national ASD consortium genome-wide association study that also collected information about sleep patterns, we sought in the present study to fill this gap in knowledge by relating variation in and around 25 melatonin synthesis and SCN genes to their influence on sleep problems in children with ASD. We chose genetic variants for association analysis based on their impact on gene expression, as measured by RNA-Seq and single nucleotide polymorphism (SNP) data.
Method Participants
The Simons Foundation Autism Research Initiative started the SSC with the primary goal of identifying genetic variants that contribute to ASD risk. The sample of approximately 2,750 simplex families (only one child with ASD per family) was recruited from 12 academic medical centers in the United States and Canada. Procedures of the original SSC study and characteristics of the sample have been described previously (Fischbach & Lord, 2010; Frazier, Georgiades, Bishop, & Hardan, 2014; Johansson, Feeley, Dorman, & Chasens, 2018; Lord et al., 2012) . Strict phenotyping was performed on children with ASD, aged 4-18 years, using parent interview, medical history, and multiple well-validated instruments. Clinical best estimate diagnoses of autism or ASD were given based on medical history and chart review, the Autism Diagnostic Observation Schedule (ADOS; Lord et al., 1989) and Autism Diagnostic Interview-Revised (Lord, Rutter, & Le Couteur, 1994) 
Procedures
Procedures of the parent study, inclusion and exclusion criteria, and characteristics of the SSC study sample have been described previously (Fischbach & Lord, 2010; Frazier et al., 2014; Johansson, Feeley, et al., 2018; Lord et al., 2012) . The current study was a secondary analysis of existing genotypic and phenotypic data from the Simons Foundation. Informed consent was obtained for the SSC study from parents or caregivers, and assent was obtained from children as required by local institutional review boards. We obtained approval from the University of Pittsburgh Institutional Review Board for the current study. The Simons Foundation de-identified data prior to transmitting to the present researchers.
Demographic data (age, sex, etc.) were collected when families entered the SSC study. Phenotypic data were obtained from the Simons Foundation software platform, SFARI Base. Data were cross-sectional, and participants were not recontacted for follow-up. Previous analysis of the sample revealed associations between sleep problems and nonverbal IQ (NVIQ), Autism Diagnostic Observation Scale (ADOS) total score, and presence or absence of gastrointestinal distress (GID; Johansson, Feeley, et al., 2018) . We used these variables, with the addition of seizures, sex, age, and ancestry, as covariates in the present analyses. GID was defined as parent reports of bloating/excess gas, celiac disease, constipation, diarrhea, ulcers, gastroesophageal reflux disease, inflammatory bowel disease (Crohn's disease, ulcerative colitis), irritable bowel syndrome, abdominal pain, unusual stools, vomiting, and/or other GID. Seizures were defined as parent reports of atonic drop, infantile spasms, or partial complex, grand mal, petit mal, simple partial, and/or other seizures. We determined presence or absence of GID and seizures for the present study using data from the medical history interview conducted as part of the parent study at baseline. The SSC researchers used four norm-referenced instruments to measure NVIQ in their sample based on chronologic and mental age: the Differential Ability Scales-II (Elliott, 2012) , Wechsler Intelligence Scale for Children, fourth edition (Wechsler, 2003) , Wechsler Abbreviated Scale of Intelligence (Wechsler, 2011) , and Mullen Scales of Early Learning (Bradley-Johnson, 1997) . The ADOS (Gotham, Pickles, & Lord, 2009; Lord et al., 1989 ) is a semistructured observational instrument used with other instruments for diagnosis of ASD and classification of severity. It measures social responsiveness, communication, language delay, and spatial ability.
Instruments
The SSC Sleep Interview (SSCSI; Johansson, Rohay, & Chasens, 2018 ) is an 11-item cross-sectional, parent-report questionnaire evaluating nighttime and daytime sleep problems and sleep duration problems (Table 1 ). The SSCSI was developed in 2017 through principle components analysis of items from the SSC medical history. Full-scale reliability was adequate (a ¼ .694), but the scale has not yet been independently validated or tested in another sample of children with ASD. Items are scored as 0 for no and 1 for yes. A continuous composite score is made by summing the 10 dichotomous items plus 1 point added for reported sleep duration outside National Sleep Foundation recommendations based on the child's age (Hirshkowitz et al., 2015) . Composite scores range from 0 to 11, with higher scores indicating worse sleep. Subscale scores are determined by summing the items within each subscale (Nighttime Problems and Daytime Problems range ¼ 0-4; Sleep Duration Problems range ¼ 0-2). We excluded participants from the present analysis if more than 2 items on this instrument were missing or coded as unknown.
Gene Variant Selection
We chose expression quantitative trait loci (eQTLs) or genomic variants that influence the expression of one or more genes, primarily using gene expression data from the CommonMind Consortium (CMC; Fromer et al., 2016) . The CMC used RNASeq data from dorsolateral prefrontal (DLPFC) brain tissue from adults with and without neuropsychiatric disorders (Albert & Kruglyak, 2015) . We also took variants from the Genotype-Tissue Expression (GTEx; GTEx Consortium, 2015) project and HaploReg Version 4 (Ward & Kellis, 2016) as well as using variants identified by other groups as affecting sleep patterns in individuals with ASD (Melke et al., 2008; Veatch et al., 2015; Yang et al., 2016 ).
For the current study, we analyzed gene expression in cis-(within 1 MB of gene) variants with a false discovery rate threshold .05, revealing that 17 of the 25 genes were expressed in substantial quantities in the CMC DLPFC data (ARNTL, BHLHE40/41, CLOCK, CRY1, CSNK1D/E, DBP, GAD1/2, NR1D2, PER1/2/3, RORA/B, TPH2). We used data from the GTEx project to identify eQTLs for seven of the eight remaining genes (MTNR1B, CRY1, DDC, AANAT, PROK2, CIART, TIMELESS). For MTNR1A, we found 2,149 variants in the Haploreg Version 4 program using the location of the gene plus 50 KB on each side (chr4:187404809-187526537). Of these, 12 variants had data for expression. We chose those eQTLs with a p value <.001 and used the independent pairwise function in Plink to prune the list based on linkage disequilibrium (LD) and an r 2 ¼ .5. We used SNAP Proxy Search to find proxy eQTLs for some eQTLs that were not available in the SSC (Broad Institute, 2015) . These processes resulted in 73 eQTLs from the CMC; 49 were available in SSC data (32 proxy eQTL in significant LD were substituted for eQTLs not in SSC data). Of the 40 eQTLs from GTEx, 16 were available in the SSC data (12 proxy eQTLs were substituted). Haploreg identified eight eQTLs; three were available in SSC data (one proxy eQTL was used). Of the 26 variants identified by previous literature in 10 genes (ASMT, CLOCK, CSNK1E, MTNR1A/B, NR1D1, PER1/2/3, TIMELESS), 4 were available in the SSC data (2 proxies were used): ASMT rs4446909 was identified by Melke et al. (2008) and Veatch et al. (2015) ; PER2 rs934945, PER3 rs10462020 (proxy: rs10462021), and PER3 rs228697 (proxy: rs228690) were identified by Yang et al. (2016) . In all, 73 independent eQTLs or variants were identified (CMC ¼ 50, GTEx ¼ 16, Haploreg ¼ 3, literature ¼ 4; Supplemental Table S1 ).
Individuals in the SSC sample were genotyped using Illumina 1Mv1 (approximately 325 families), Illumina 1Mv3 Duo (approximately 1,160 families), or Illumina HumanOMNI 2.5 (approximately 625 families) arrays. The same array version was used to analyze all members of a family.
Statistical Analyses
Binary items, including SSCSI items, composite and subscale scores, and sex, were described using frequency counts and percentages. Parent-reported regular sleep duration (hours per night) and age (years) were described using mean, standard deviation, and range. Regular sleep duration less than 3 standard deviations below the population mean was replaced with the third standard deviation below the mean (4.85 hr). MannWhitney U test was used to compare SSCSI composite and subscale scores between age groups and w 2 analyses to compare between sexes. Descriptive and correlational analyses were performed with SPSS, Version 23 (SPSS Inc., Chicago, IL).
Power analysis was conducted using the Genetic Power Calculator (Purcell, Cherny, & Sham, 2003) . Power to detect factors associated with sleep patterns was calculated assuming 72 independent tests, resulting in a Bonferroni-corrected significance level of 0.05/72 or p ¼ .0007. Given the large size of Note. Items 1-10 are scored as 0 points for answers of no and 1 point for yes; 1 point is given for Item 11 if the regular sleep duration is outside recommended hours for the child's age per the National Sleep Foundation.
the SSC database, the present study was well powered (!80%) to detect an odds ratio (OR) of 1.2 for a common variant (risk allele frequency ¼ 0.5) or a less common variant (risk allele frequency ¼ 0.25, p ¼ .0007).
Logistic regression analysis. SSCSI composite and subscale scores were dichotomized into none/minimal sleep problems (SSCSI scores 0-1) or sleep problems present (SSCSI scores ! 2). Logistic regression analyses were performed to estimate associations between SSCSI composite and subscale scores and individual variant reference allele dosage (0, 1, 2 alleles). Hardy-Weinberg equilibrium (HWE) was assessed in participants of non-Hispanic European ancestry using the Hardy Weinberg package in the R suite (R Core Team, https://www.r-project.org/) and a p < .0007 (Bonferroni correction). All variants were in HWE. All models were adjusted for age (years), ADOS severity score (range
¼ African American) and were performed under the additive genetic model (0, 1, 2 alleles). Analyses were performed by building models with no sleep problems versus sleep problems (mild or moderate/severe) as the outcome variable.
ORs with 95% confidence intervals were used to measure the strength of associations between each gene variant and sleep patterns. Logistic regression was performed with the MASS package in the R Suite. Level of significance was set at p < .0007 (Bonferroni correction).
Transmission disequilibrium test (TDT).
The TDT, one of several family-based association methods, examines expected and observed transmission of parental genotypes or alleles to offspring affected by a disease or trait. Transmission disequilibrium occurs when there is nonrandom or greater-thanexpected transmission of a certain allele to offspring with a trait or disease (Laird & Lange, 2011) . The TDT was performed with parent-child trios in which the child had SSCSI composite and subscale sleep problems present using Bioconductor trio package in the R Suite (Schwender et al., 2015) . Level of significance was set at p < .0007 (Bonferroni correction). Only variants in which more than 100 trios were tested are reported.
Results

Sample Characteristics
Characteristics of the sample are presented in Table 2 . Of the full sample of children with genetic data available (N ¼ 2,200), we excluded 135 for missing sleep data. Of those excluded, three fourth (78-80%) were also missing descriptive data (age, ancestry, diagnosis, ADOS severity score, NVIQ, and sleep duration), so that comparisons between children included and excluded from the sample were not feasible. There was no significant difference in sex between those included and excluded (p ¼ .42). The sample was predominantly male (87%), non-Hispanic European (78%), did not have seizures (95%), and had NVIQ above 70 (75%). Exactly half of the sample had GID. The mean age of the sample was approximately 9 years (range ¼ 4-18 years). Children below the mean age were significantly more likely than children over the mean age to have an NVIQ <70 (40.2% vs. 33.0%, respectively, p < .05), to have seizures (6.9% vs. 4.3%, respectively, p < .01), and to have sleep problems (scores ! 2) on the SSCSI composite (76.3% vs. 61.6%, respectively, p < .01) and nighttime sleep problem subscale (38.2% vs. 30.7%, respectively, p < .05). Younger children also had significantly longer sleep duration than older children (mean ¼ 9.5 [SD 1.3] hr vs. 8.8 [SD 1.2] hr, p < .01). The ratio of males to females in the present sample was 6.6:1 (national average of children with ASD: 4:1; Baio et al., 2018) . We found no significant differences between males and females in regular sleep duration, age, proportion of children with GID, seizures, or sleep duration less than recommended for age. Significantly more females had NVIQ 70 (37.6% vs. 23.7%, p < .01).
Genotype Associations With SSCSI Sleep Problems
While no genetic associations remained significant after applying correction for multiple testing, due to the hypothesisgenerating nature of the study, we will discuss results that meet the conventional p < .05 cutoff. Table 3 lists those eQTLs associated (p < .05) with sleep problems (mild or moderate/ severe vs. none) based on SSCSI composite and subscale scores. Composite sleep problems were most highly associated with the CRY1 eQTL rs1035768, RORA eQTL rs8038644, and the GAD1 eQTL rs16857804. Nighttime sleep problems were most highly associated with the MTNR1B eQTL rs1962041 and were also associated with PER2 eQTLs rs6431588 and rs934945 and the RORA eQTL rs8038664. Daytime sleep problems were most highly associated with the MTNR1B eQTL rs11598 and were also associated with the GAD1 eQTL rs16857804 and the CLOCK eQTL rs11943456. Sleep duration problems were most highly associated with the GAD2 eQTL rs11014824 and were also associated with the DDC eQTL rs3735274 and the GAD2 eQTL rs7077123.
TDT
No variants showed statistically significant overtransmission of alleles from parents to children with sleep problems after adjustment for multiple testing (p < .0007; Table 4 ). Sleep duration problems did not have any variants with >100 trios. The variant associated with the highest odds of sleep problems in the TDT analysis was CIART eQTL rs28730724, which displayed overtransmission of the A allele in children with composite sleep problems. RORA eQTL rs4775351 displayed overtransmission of the A allele in children with composite and daytime problems. Overtransmission of the A allele was shown in two eQTL of CSNK1E: rs135721 with composite sleep problems and rs4296527 with daytime problems. Two CLOCK eQTL were associated with overtransmission of alleles to children with daytime problems: rs693367 showed overtransmission of the A allele, and rs11943456 of the G allele. GAD1 eQTL rs13395562 and MTNR1B eQTL rs11598 also showed overtransmission of the G allele in children with daytime problems. Only one eQTL, PER2 rs6431588, showed overtransmission to children with nighttime problems.
Discussion
This study represents the first analysis of relationships between variation in genes of both the melatonin synthesis and core SCN pathways and sleep problems in children with ASD from the SSC. To investigate these associations, we performed logistic regression on 72 variants (68 eQTLs and 4 SNPs) in 25 genes and sleep problems-SSCSI composite sleep problems score, Nighttime Problems subscale score, Daytime Problems subscale score, and sleep duration problems-controlling for age, sex, total ADOS severity score, NVIQ, presence of GI distress and seizures, and ancestry. To corroborate association findings, we investigated transmission disequilibrium between parents and children affected by sleep problems. Our analyses revealed no variants significantly associated with sleep problems, and we found no evidence for overtransmission of alleles Note. Results with p < .05 and trios with n > 100 are displayed. There were no trios with n > 100 for the Sleep Duration Problems subscale. There were no significant results after Bonferroni correction (p < .0007). OR ¼ odds ratio.
from parents to children with ASD affected by sleep problems. We can thus conclude with some confidence that eQTLs and SNPs for the investigated genes in the melatonin synthesis and core SCN pathways do not have a notable impact on sleep problems in children with ASD.
Strengths and Limitations
A number of strengths lend credence to the results of this study. While many previous studies have been limited in their ability to identify meaningful associations between genomic and biochemical variants and sleep patterns by small sample sizes and the choice of only one or two genes, the present study presents a comprehensive analysis of 25 genes with more than 2,000 strictly phenotyped children. A unique aspect of this study is the a priori selection of eQTLs that affect transcription of these genes in the brain. A majority of eQTLs chosen came from the CMC, which mined gene expression data from the brain tissue, including tissue from individuals with schizophrenia, a neurobehavioral disorder with genetic similarities to ASD (Autism Spectrum Disorders Working Group of the Psychiatric Genomics Consortium, 2017; O'Connell, Mcgregor, Lochner, Emsley, & Warnich, 2018) . The innovative use of RNA-Seq data to select gene variants affecting target gene expression may help to explain why our results diverged from those of other groups who chose variants based on previous literature (Veatch et al., 2015) or whole-exome sequencing (Chaste et al., 2010; Melke et al., 2008; Yang et al., 2016) . While these groups looked at associations with structural mutations in the genes or posttranslational melatonin levels, in the present study, we investigated associations with variation in transcription or gene expression. The size of the SSC sample was also a key strength of this study, even with a large number of tests performed. This study was powered to detect effects of approximately 1% of variability in sleep problems, yet we did not detect significant effects of gene variants after correction for multiple testing. The use of TDT also augments power by eliminating the problem of population stratification. The present study had several limitations. As neither the CMC nor GTEx collected samples with consideration of timing of circadian gene expression, the choice of eQTL may not capture markers that were not expressed at the time of sample collection. The CMC used samples from the brains of adults, which may exhibit different gene expression patterns than the brains of children. In addition, using secondary data precludes the use of different sleep questionnaires or the measuring of levels of hormones related to sleep patterns, like melatonin and cortisol. Conversely, studies such as this one require large samples, and it is almost impossible to muster a sample of the necessary size in which hormones were measured directly. Although the present study had a large sample, if the effects of the variants were small, the current sample size might not have been adequate to detect them. Finally, the SSCSI was developed for use with the SSC and has not been independently validated or used with other samples of children with ASD. The SSCSI was also based on parents' report and thus may be subject to reporting bias. Additional objective measures might provide further insight.
Implications
Continued research into the genomics of sleep problems in individuals with ASD is necessary. The lack of association that we found between expression of genes and sleep patterns in the present study does not imply that the melatonin synthesis and SCN pathways should be abandoned for future inquiry. Although the present findings showed that transcription of these genes was not influencing sleep patterns, the effects of translational and posttranslational modification on melatonin and SCN proteins cannot be dismissed. That a number of research studies have shown low melatonin or melatonin metabolite levels (Leu et al., 2011; Melke et al., 2008; Tordjman et al., 2005) as well as success with melatonin supplementation (Cuomo et al., 2017; Gringras, Nir, Breddy, Frydman-Marom, & Findling, 2017; Wright et al., 2011) demonstrates that these pathways are still valid research areas. However, as other gene pathways in the brain and body, such as glutamate, GABA, and serotonin, are known to interact with melatonin and the SCN, inquiries should not be limited to the melatonin/SCN pathways.
Conclusion
In the present study, we found that variation in the expression of core genes in the melatonin synthesis and SCN pathways did not have notable impacts on sleep problems in a large sample of children with ASD based on logistic regression and TDTs. These results may differ from those of previous investigations of the genetics of sleep problems in ASD due to the innovative use of expression data to guide gene variant selection and because of the much larger size of the current sample. This study may be of use in clarifying genomic mechanisms related to the melatonin/SCN pathways and sleep problems in ASD and in suggesting further lines of inquiry. Future research might explore translational and posttranslational effects of these genes, the effects of genes in other sleep-homeostasis pathways on sleep patterns, and the use of objective measures of sleep.
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